Hill Dermaceuticals, Inc. v. U.S. Food & Drug Administration

891 F. Supp. 2d 1, 2012 U.S. Dist. LEXIS 187663, 2012 WL 4044868
CourtDistrict Court, District of Columbia
DecidedMay 8, 2012
DocketCivil Action No. 11-1950 (RCL)
StatusPublished

This text of 891 F. Supp. 2d 1 (Hill Dermaceuticals, Inc. v. U.S. Food & Drug Administration) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hill Dermaceuticals, Inc. v. U.S. Food & Drug Administration, 891 F. Supp. 2d 1, 2012 U.S. Dist. LEXIS 187663, 2012 WL 4044868 (D.D.C. 2012).

Opinion

ORDER

ROYCE C. LAMBERTH, Chief Judge.

Upon consideration of plaintiffs Motion [59] for summary judgment, Federal defendants’ opposition and Motion [71, 78] to dismiss, intervenor defendant’s opposition and Cross-Motion [68] for summary judgment, plaintiffs reply and response [80], Federal defendants’ reply [87], intervenor defendant’s reply [82], the administrative record, the applicable law, and the entire record in this case, it is hereby

ORDERED that plaintiffs Motion [59] for summary judgment is DENIED; and it is further

ORDERED that defendants’ Motions [68, 71, 78] for summary judgment are GRANTED.1

Upon consideration of plaintiffs Motion [89] for leave to file two supplemental declarations, Federal defendants’ opposition [90], plaintiffs reply [92] thereto, intervenor defendant’s opposition [93], plaintiffs reply [95] thereto, the applicable law, and the entire record in this case, it is hereby

ORDERED that plaintiffs Motion [89] for leave to file is DENIED.

Summary judgment is hereby entered for defendants, and this case shall stand DISMISSED WITH PREJUDICE. It is further

ORDERED that Federal defendants shall file within 20 days of the date of the issuance of this Order a proposed redacted version of the accompanying Memorandum Opinion that could be released to the public and the other parties in this case. If Federal defendants fail to submit a timely response, they will be deemed to have consented to a full unsealing of the Memorandum Opinion.

SO ORDERED.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
891 F. Supp. 2d 1, 2012 U.S. Dist. LEXIS 187663, 2012 WL 4044868, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hill-dermaceuticals-inc-v-us-food-drug-administration-dcd-2012.